Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (Weighted Average) (2022 - 2025)

Cannabis Bioscience International Holdings' Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $11.6 billion for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 10.76% year-over-year to $11.6 billion; the TTM value through Nov 2025 reached $11.6 billion, up 10.76%, while the annual FY2025 figure was $10.7 billion, 3.86% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $11.6 billion at Cannabis Bioscience International Holdings, roughly flat from $11.6 billion in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $11.6 billion in Q3 2025 and bottomed at $8.7 billion in Q1 2023.
  • The 4-year median for Shares Outstanding (Weighted Average) is $10.3 billion (2023), against an average of $10.3 billion.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 18.26% in 2024 against a maximum downside of 1.23% in 2024.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $8.8 billion in 2022, then increased by 17.61% to $10.3 billion in 2023, then increased by 1.6% to $10.5 billion in 2024, then increased by 10.76% to $11.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Shares Outstanding (Weighted Average) are $11.6 billion (Q4 2025), $11.6 billion (Q3 2025), and $10.7 billion (Q2 2025).